Product Information
NEXTSTELLIS 3-14.2 MG TABLET is a brand product labeled by Mayne Pharma, priced at $7.6675 per EA under NDC 51862025801. Its NADAC has been published 233 times since Apr 20, 2022.
FDA first approved this application on Apr 15, 2021.
Manufacturer
Mayne PharmaNDC
51862025801
Classification
Brand
Dosage Form
KIT
Effective Date
6/1/2026
Approval Type
New Drug (NDA)
FDA Application
NDA214154FDA Approved
4/15/2021
On Market Since
4/16/2021
Price Statistics
The NADAC for NEXTSTELLIS 3-14.2 MG TABLET has been published 233 times since Apr 20, 2022, and over the history we have for it it has risen 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.6675 per EA |
|---|---|
| All-time high | $7.6675 (Sep 30, 2026) |
| All-time low | $6.4886 (Apr 20, 2022) |
| 52-week high | $7.6675 |
| 52-week low | $7.2935 |
| Median price | $7.2935 |
| Average price | $7.0855 |
| Largest weekly change | +7.0% (Dec 28, 2022) |
| Weeks tracked | 233 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the drospirenone and estetrol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
drospirenone and estetrol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEXTSTELLIS 3-14.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEXTSTELLIS 3-14.2 MG TABLET, manufactured by Mayne Pharma, is $7.6675 per EA (NDC 51862025801), effective Sep 30, 2026.
How has the price of NEXTSTELLIS 3-14.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEXTSTELLIS 3-14.2 MG TABLET has risen 18.2%. It has been tracked across 233 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for NEXTSTELLIS 3-14.2 MG TABLET?
Since Apr 20, 2022, the NADAC for NEXTSTELLIS 3-14.2 MG TABLET has ranged from a low of $6.4886 (Apr 20, 2022) to a high of $7.6675 (Sep 30, 2026), with a median of $7.2935 per EA.
Are there cheaper alternatives to NEXTSTELLIS 3-14.2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NEXTSTELLIS 3-14.2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEXTSTELLIS 3-14.2 MG TABLET?
NEXTSTELLIS 3-14.2 MG TABLET (NDC 51862025801) is labeled by Mayne Pharma, and CMS classifies it as a brand product.